Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos

Inward Investment
Return to: PBR Home | Inward Investment | News
Search Refinements

Inward Investment News

View news from other Pharmaceutical sectors:
136-150 of 421 results
Navidea opens business, commercial development office in Massachusetts
By PBR Staff Writer
US-based specialty pharmaceutical company, Navidea Biopharmaceuticals has opened a business and commercial development office in Andover, Massachusetts, US.
Inward Investment > News
Alexion takes over Enobia
By PBR Staff Writer
Alexion Pharmaceuticals has completed its acquisition of 100% of the capital stock of Enobia Pharma, a private biopharmaceutical company.
Inward Investment > News
Medicago to invest in pilot production facility
By PBR Staff Writer
Medicago has announced plans to invest around $4m to increase the capacity of the pilot production facility located in Quebec City, the capital of the Canadian province of Quebec.
Inward Investment > News
Sigma-Aldrich takes over BioReliance for $350m
By PBR Staff Writer
Sigma-Aldrich, a life science and high technology company, has completed its purchase of BioReliance from Avista Capital Partners for $350m in cash.
Inward Investment > News
Mission Pharmacal launches new subsidiary
By PBR Staff Writer
Mission Pharmacal Company has launched a new Doylestown, Pennsylvania, based subsidiary, Alamo Pharma Services.
Inward Investment > News
Watson Pharmaceuticals buys Ascent Pharmahealth
By Ruby Zoe
Watson Pharmaceuticals has purchased Ascent Pharmahealth, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab.
Inward Investment > News
OPKO to acquire ALS Distribuidora
By Ruby Zoe
OPKO Health has signed a definitive agreement to acquire ALS Distribuidora Limitada, a privately-held Chilean pharmaceutical company.
Inward Investment > News
PolyTherics purchases Warwick Effect Polymers
By Ruby Zoe
PolyTherics has purchased Warwick Effect Polymers (WEP), a provider of specialty biopolymers for the modification of biological products.
Inward Investment > News
UK biotech firm takes over Warwick Effect Polymers
By PBR Staff Writer
UK-based biotech company, PolyTherics, has acquired Warwick Effect Polymers (WEP), a provider of specialty biopolymers for the modification of biological products.
Inward Investment > News
LTS Nutraceuticals acquires Biocalth
By PBR Staff Writer
LTS Nutraceuticals, a manufacturer of nutritional and personal care products, has acquired Biocalth International, Giantceuticals, and HerbSource Enterprises (collectively Biocalth).
Inward Investment > News
Carbogen Amcis acquires Creapharm Parenterals
By PBR Staff Writer
Dishman Pharmaceuticals & Chemicals' unit Carbogen Amcis has acquired French contract development and manufacturing company, Creapharm Parenterals.
Inward Investment > News
Novartis to restructure US business
By PBR Staff Writer
Novartis Pharmaceuticals has announced plans to restructure US business and reduce its cost base with the current restructuring focused on the US market.
Inward Investment > News
Vanda inks Fanapt licensing deal with Megapharm
By PBR Staff Writer
Vanda Pharmaceuticals has signed an exclusive license agreement with Israel's private biotech, pharmaceutical and medical nutrition marketing company- Megapharm, for the commercialization of Fanapt in Israel.
Inward Investment > News
Semler plans Asian expansion with ACA
By PBR Staff Writer
Semler Research Center of India, a part of Part of US-based Semler Group of Companies, has announced that it will expand its operations across Asia by introducing the 'Asia CRO Alliance.' (ACA).
Inward Investment > News
Nipro to invest in JMI Pharma in Bangladesh
By PBR Staff Writer
Japan-based Nipro has announced to invest in JMI Pharma, a pharmaceutical company in Bangladesh.
Inward Investment > News
136-150 of 421 results